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In the early development of modern medicine, biologically active compounds from higher plants have played a vital role in providing medicines to combat pain and diseases. For example, in The British Pharmacopoeia of 1932 (1) , over 70% of organic monographs were on plant-derived products. However, with the advent of synthetic medicinals, and subsequently of antibiotics, the role of plantderived therapeutic agents significantly dedined (mostly) in the economically developed nations. Thus, in the 1980 edition of the The British Pharmacopoeia (2) , the share of plant-based monographs fell to approximately 20%. In terms of new chemical entities introduced as medicinal agents over the past several decades, the share of plant-based drugs has been no more than 2% (3) . However, plant-derived medicinals continue to occupy an important niche in the treatment of diseases worldwide. Thus, most of the recently introduced plant-based drugs have been innovative in character and represent outstanding contributions to therapeutics. These drugs include several anticancer agents such as podophyllotoxin, paclitaxel, camptothecin, or compounds based on these as lead structures; each of these classes of compounds exhibit their anticancer activity by distinct mechanisms (3) . It has been estimated that in the United States, 25% of all prescriptions dispensed from community pharmacies during the period 1959-1980 contained plant extracts or active principles derived therefrom (4) . Even now, 75-80% of the world population depends on crude plant drug preparations to treat their health problems, although this may be mostly because of economic considerations.
In the last two decades, there has been a new trend in the preparation and marketing of drugs based on medicinal plants (3, (5) (6) (7) (8) .
These preparations, labeled herbal drugs or phytomedicines, are single plant extracts or fractions thereof and are distinct from the pure chemical entities of molecular drugs (3) . These new plant-derived products are carefully standardized, and their efficacy and safety for a specific application have been demonstrated. The present global market for these products has been estimated to be approximately $20 billion U.S. and is growing at the rate of 15-20% annually (3) .
Thus, plant-based therapeutic agents continue to have scientific, social, and commercial significance and appear to be gathering a momentum in health-relevant areas.
A study of the process by which the traditional or more recent plant-based molecular drugs or the new breed of herbal drugs came to be used in present-day medicine reveals that, in over 70% of the cases, the starting point has been some reference to the use of that plant as an indigenous cure in a folklore or traditional system of medicine of one culture or another. Some examples are codeine, ephedrine, quinine, and emetine among the traditional molecular drugs; reserpine, artemisinin, and podophyllotoxin (lead structure) from the period after the traditional molecular drug era; and garlic, ginseng and St. John's wort of the currently popular herbal drugs. Thus, this paper highlights the modern drug discovery potential of the plants described in various traditional systems of medicine or in the folklore of various countries, which has been previously emphasized (3, (9) (10) (11) (12) . It is with this background that I would like to discuss the potential of and opportunity in Ayurvedic materia medica. However, it seems appropriate to briefly describe Ayurveda for those not familiar with this Indian heritage.
Ayurveda
The origin of Ayurveda has been lost in prehistoric antiquity, but its characteristic concepts appear to have matured between 2500 and 500 B.C. in India. The word "Ayurveda" is derived from "ayus (r)," meaning life, and "veda," meaning knowledge; thus, Ayurveda 
Ayurvedic Drugs
There are approximately 1,250 Indian medicinal plants (25) (26) , and this book was revised and updated in 1958 (27) Two publications (33, 34) have attempted to cover these findings. In a significant number of cases, current data from these and other studies corroborate the main claims of these plants according to traditional use. Some examples are shown in Table 2 . This concordance is meaningftl; to emphasize its scientific, commercial, and social potential, I would like to elaborate on some of these examples.
Psoralea corylifolia (bakuchi). This is an erect annual found almost throughout India. Its seed powder is valued in Ayurveda for the treatment ofvitiligo, psoriasis, and inflammatory diseases of the skin (67) . Chemical and pharmacologic investigations (29, 68, 69) led to the isolation of the active principle, psoralen (Figure 1 ), in the mid-1930s; psoralen has been shown to stimulate the formation of melanin (70) . Psoralen is used therapeutically for the treatment of leucoderma. More recent investigations have led to the isolation of the meroterpene bakuchiol (Figure 1 ) (71) (72) (73) and other related compounds (74) . Bakuchiol has been shown to posses potent antibacterial activity (29) and is useful for the treatment of psoriasis (75) . Recently, bakuchiol has been shown to be a DNA polymerase inhibibitor (76) .
Rauwolfia serpentina (sarpagandha). This is a famous Ayurvedic plant because it represents the earliest (-1950 (in 1952) in isolating the sedative principle, reserpine, a minor alkaloidal constituent. Reserpine was introduced in the market in 1953 and was heralded as a revolutionary event in the treatment of hypertension, as it had the twin effect of lowering high blood pressure and acting as a tranquillizer (64) .
Asparagus racemosus (shatavari). Roots of Asparagus racemosus are reputed in Ayurveda as galactagogue, and preparations based on this drug (e.g., Shatavari sidh ghrit) are often recommended in cases of threatened abortion (28,7X) . This plant contains several glycosides, and one of these, shatavaran-I (Figure 1) (41, 42 , has been shown to block oxytocin-induced contractions in rat, guinea pig, and rabbit uteri in vivo and in situ (78) .
Galactagogue activity has also received some experimental support (43) .
Cedrus deodara (devadaru). Wood of the
Himalayan cedar has several medicinal attributes, and preparations based on this plant are used to treat cough, bronchitis, and skin diseases, among others (79) . An oil obtained from the wood is used in villages for treating insect infestations on animals; there is sufficient experimental support for this (80) . The essential oil of the wood has been thoroughly examined chemically (81) (82) (83) . Himachalol (Figure 1) , one of the constituents of the essential oil, has been shown to possess potent spasmolytic activity (50, 51) . Activity-guided fractionation led to the identification of himachalenes (Figure 1) (80:20) . 1'These represent ketonic and nonketonic fractions of the neutral cut of the total ethyl acetate-soluble portion of the gum resin (15) . Data from Nand (99). (ashwagandha) Abbreviations: AChE, acetylcholine esterase; ACE, angiotensin-converting enzyme; GABA (AB), y-aminobutyric acid; NGF, nerve growth factor; NI, not investigated; NMDA, N-methyl-D-aspartic acid. The appropriate plant part, as recommended in Ayurveda, was extracted with methanol by room temperature percolation. For biological screening, the methanol-free extract was taken up in aqueous DMSO to get 5 pg of the material/mL. Learning, memory, and cognitive disorders. This area of research was selected for three reasons: a) there is a paucity of modern drugs/agents facilitating acquisition, retention, and retrieval of information and knowledge; b) with the increasing number of elderly people in the world population, the need for drugs to treat cognitive disorders, such as senile dementia and Alzheimer disease, have acquired special urgency; and c) Ayurveda claims that several plants, the so-called "medhya" plants, possess such activities.
The past two decades have seen tremendous advances in the area of brain physiology, learning, memory, and various brain disorders, and a host of mechanisms at molecular level have been delineated (104) (105) (106) . Synapses-the junctions of nerve cells representing the basic interactive unit of neuronal circuits-constitute the fundamental systemic relationship within the brain. Understanding how this interactive multitude of neuronal circuitry is established initially, and refined continuously throughout life, is fundamental to understanding the molecular basis of learning and memory. At present, an impressive array of chemical entities affecting synapse formation, neuronal differentiation, neurotransmission, nerve growth and repair, and several other functions are recognized. Approximately 50 neurotransmitters belonging to diverse chemical groups have been identified in the brain (107) . Receptors, which are activated by these chemicals, assume special importance in the present context. Specifically, N-methyl-D-aspartic acid (NMDA) and y-aminobutyric acid (GABA) receptors have been implicated in learning and memory (108) (109) (110) (111) . It has been further postulated that GABAB antagonists may enhance memory (108) , whereas the NMDA receptor has the ability to mediate synaptic plasticity (111) . Acetylcholine, the first neurotransmitter to be characterized, has a very significant presence in the brain; recently, Winkler et al. (112) determined that acetylcholine is essential for learning and memory. Acetylcholine has been a special target for investigations for almost two decades because its deficit, among other factors, has been held responsible for senile dementia and other degenerative cognitive disorders, including Alzheimer disease (113) (114) (115) (116) . Approximately 5% of the neurons in the (117) , which are vital for normal functioning of the brain. Thus, nerve growth factor has an important role to play. Several reports have suggested that angiotensin-converting enzyme inhibitors (e.g., captopril) may indirectly lead to improved cognitive performance (116) . There are several other factors [e.g., gonadal steroid receptors (118, 119] , that have a bearing on learning and memory, but they are not relevant to the current work.
The knowledge about neurotransmitters, enzymes, growth factors relevant to memory and learning, and cognitive disorders is already being used for the discovery and development of suitable therapeutic agents (120, 121 (122) (123) (124) .
Over the past 10-15 years, there has been much activity in the development of potent and selective CCK agonists and antagonists because these agents may lead to novel therapy for the treatment of disorders such as gastrointestinal disturbances, pancreatitis, gastric and pancreatic carcinomas, obesity, and cognition dysfunction, in which CCK has been implicated. Several such molecules are under active development (124) . There are also satiety agents, fashioned after CCK, which may fight obesity (125) .
It seemed worthwhile to evaluate the three components of Triphala (three fruits), an Ayurvedic remedy for treating various gastrointestinal disorders. The three fruits are products of Terminalia chebula (Sanskrit: haritaki), Terminalia bellerica (bibhitaka), and Emblica officinalis (aamalaki); haritaki has also been recommended in Ayurveda for treatment of obesity. The methanol-extracted material from the three fruits was evaluated in vitro by radioligand binding assays (Table 6 
